Human immunoglobulin (pH4) (Japan Blood Products Organization)

人免疫球蛋白（pH4）（日本血液制品机构）

Report date: 2022/03/08 10:47:12

Base Information

Drug NameHuman immunoglobulin (pH4) (Japan Blood Products Organization)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAgammaglobulinemiaPurpura, Thrombocytopenic, IdiopathicMucocutaneous Lymph Node Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJapan Blood Products Organization
China Registration ClassN/A

Develop Information

Active CompaniesJapan Blood Products Organization
Inactive CompaniesN/A
Active IndicationsAgammaglobulinemiaPurpura, Thrombocytopenic, IdiopathicMucocutaneous Lymph Node Syndrome +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A